Laurent Thion

Title: Laurent Thion: Innovator in Monoclonal Antibodies

Introduction

Laurent Thion is a notable inventor based in Bourg de Thizy, France. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies targeting influenza viruses. His work has implications for vaccine development and therapeutic interventions.

Latest Patents

Thion holds a patent for "Flu virus hemagglutinin specific monoclonal antibodies." This invention relates to a monoclonal antibody that recognizes an antigenic structure present on both the H1 and H3 subtypes of hemagglutinins of type A flu viruses, as well as on the hemagglutinin of type B flu viruses. Within type B flu viruses, the antigenic structure is found on hemagglutinins belonging to the B/Victoria group and/or the B/Yamagata group. He has 1 patent to his name.

Career Highlights

Throughout his career, Laurent Thion has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur SA and Sanofi Pasteur Inc. His experience in these organizations has allowed him to contribute to significant advancements in vaccine technology and antibody development.

Collaborations

Thion has collaborated with esteemed colleagues such as Catherine Moste and Isabelle Legastelois. These partnerships have fostered innovation and have been instrumental in the progress of his research.

Conclusion

Laurent Thion's work in the field of monoclonal antibodies represents a vital contribution to the fight against influenza viruses. His innovative approach and collaborations have the potential to enhance vaccine efficacy and improve public health outcomes.